Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.36 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12414472 | 1.00 | L3MBTL1 (0.57) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL2513753 | 1.00 | L3MBTL1 (0.57) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL10114571 | 1.00 | L3MBTL1 (0.57) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL12593224 | 1.00 | L3MBTL1 (0.57) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL24119078 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL20813037 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL21011023 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL20732492 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL20707431 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMHDAC4PTPN1 | |
| SCHEMBL17722301 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMHDAC4PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210078934-A1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL CORPORATION (JP) | 2021-03-18 | — | — | US | disclosed |
| EP-3731290-A1 | CHARGE-TRANSPORTING VARNISH | Nissan Chemical Corporation (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-20110115368-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110115368-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110115368-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-05-19 | — | — | US | disclosed |
| US-7862905-B2 | Arylamine compound and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-01-04 | — | — | US | disclosed |
| US-7862905-B2 | Arylamine compound and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-01-04 | — | — | US | disclosed |
| EP-1748681-B1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-20070285004-A1 | Arylamine Compound and Organic Electroluminescent Device | HODOGAYA CHEMICAL CO., LTD (JP) | 2007-12-13 | — | — | US | disclosed |
| US-20070285004-A1 | Arylamine Compound and Organic Electroluminescent Device | HODOGAYA CHEMICAL CO., LTD (JP) | 2007-12-13 | — | — | US | disclosed |
| EP-1748681-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2007-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110115368-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC43A1, TYR | L3MBTL1 1714/4885KDM4E 518/4885ATM 4248/4885 |
| US-20210078934-A1 | CHARGE-TRANSPORTING VARNISH | SLC43A1, SLC7A5, SLC38A7 | L3MBTL1 3087/4885KDM4E 1669/4885ATM 4199/4885 |
| US-20070285004-A1 | Arylamine Compound and Organic Electroluminescent Device | SLC7A5, SLC43A1, TYR | L3MBTL1 1714/4885KDM4E 518/4885ATM 4248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.